Figure 2.

Hazard ratios for cancer-specific mortality associated with the presence of HIV infection or solid organ transplant. Hazard ratios are from sources indicated in Supplemental Table 2. Results for virus-related cancers are shown in red and for virus-unrelated cancers in yellow. Results for cancers for which checkpoint inhibitor therapy has been approved by the US Food and Drug Administration (see Supplemental Table 3) are shown as triangles and for other cancers as circles. The dashed line indicates shows equality in hazard ratios associated with HIV and transplantation. Abbreviation: DLBCL diffuse large B-cell lymphoma.